NCT00227617 2023-05-22
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors
University of California, San Francisco
Phase 2/3 Terminated
University of California, San Francisco
Washington University School of Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center